mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.01 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.02 |